Trials / Completed
CompletedNCT00403078
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21,008 (actual)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease. The devices to be utilized are the Cordis PRECISE® Nitinol Stent Systems (5.5F and 6F) and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW).
Detailed description
Carotid Artery Stenting
Conditions
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2014-07-01
- Completion
- 2014-11-01
- First posted
- 2006-11-23
- Last updated
- 2020-08-10
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00403078. Inclusion in this directory is not an endorsement.